Clinical Trial Update: Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating eslicarbazepine acetate as monotherapy for partial epilepsy not well controlled by current antiepileptic drugs; safety and efficacy res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Epilepsy With Simple or Complex Partial Onset Seizures | Phase 3 | Status: COMPLETED | Results posted: 2016-02-04